These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 11070182)
41. MDMA alters emotional processing and facilitates positive social interaction. Wardle MC; de Wit H Psychopharmacology (Berl); 2014 Oct; 231(21):4219-29. PubMed ID: 24728603 [TBL] [Abstract][Full Text] [Related]
42. Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Young JM; McGregor IS; Mallet PE Neuropsychopharmacology; 2005 Aug; 30(8):1475-82. PubMed ID: 16178074 [TBL] [Abstract][Full Text] [Related]
43. Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. Dumont GJ; Sweep FC; van der Steen R; Hermsen R; Donders AR; Touw DJ; van Gerven JM; Buitelaar JK; Verkes RJ Soc Neurosci; 2009; 4(4):359-66. PubMed ID: 19562632 [TBL] [Abstract][Full Text] [Related]
44. Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats. Thompson MR; Hunt GE; McGregor IS Soc Neurosci; 2009; 4(1):60-72. PubMed ID: 18633827 [TBL] [Abstract][Full Text] [Related]
45. An analysis of spontaneous behavior following acute MDMA treatment in male and female rats. Pálenícek T; Hlinák Z; Bubeníková-Valesová V; Votava M; Horácek J Neuro Endocrinol Lett; 2007 Dec; 28(6):781-8. PubMed ID: 18063949 [TBL] [Abstract][Full Text] [Related]
46. Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats. Ratzenboeck E; Saria A; Kriechbaum N; Zernig G Pharmacology; 2001; 62(3):138-44. PubMed ID: 11287814 [TBL] [Abstract][Full Text] [Related]
47. MDMA does not alter responses to the Trier Social Stress Test in humans. Bershad AK; Miller MA; de Wit H Psychopharmacology (Berl); 2017 Jul; 234(14):2159-2166. PubMed ID: 28432376 [TBL] [Abstract][Full Text] [Related]
48. Effects of MDMA and Intranasal oxytocin on social and emotional processing. Kirkpatrick MG; Lee R; Wardle MC; Jacob S; de Wit H Neuropsychopharmacology; 2014 Jun; 39(7):1654-63. PubMed ID: 24448644 [TBL] [Abstract][Full Text] [Related]
49. Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats. Skelton MR; Schaefer TL; Herring NR; Grace CE; Vorhees CV; Williams MT Psychopharmacology (Berl); 2009 Jun; 204(2):287-97. PubMed ID: 19198809 [TBL] [Abstract][Full Text] [Related]
50. Recreational 3,4-methylenedioxy-N-methylamphetamine (MDMA) or 'ecstasy' and self-focused compassion: Preliminary steps in the development of a therapeutic psychopharmacology of contemplative practices. Kamboj SK; Kilford EJ; Minchin S; Moss A; Lawn W; Das RK; Falconer CJ; Gilbert P; Curran HV; Freeman TP J Psychopharmacol; 2015 Sep; 29(9):961-70. PubMed ID: 25990558 [TBL] [Abstract][Full Text] [Related]
51. Effects on rat sexual behaviour of acute MDMA (ecstasy) alone or in combination with loud music. Cagiano R; Bera I; Sabatini R; Flace P; Vermesan D; Vermesan H; Dragulescu SI; Bottalico L; Santacroce L Eur Rev Med Pharmacol Sci; 2008; 12(5):285-92. PubMed ID: 19024211 [TBL] [Abstract][Full Text] [Related]
52. Intimate insight: MDMA changes how people talk about significant others. Baggott MJ; Kirkpatrick MG; Bedi G; de Wit H J Psychopharmacol; 2015 Jun; 29(6):669-77. PubMed ID: 25922420 [TBL] [Abstract][Full Text] [Related]
53. Acute behavioural and neurotoxic effects of MDMA plus cocaine in adolescent mice. Daza-Losada M; Rodríguez-Arias M; Maldonado C; Aguilar MA; Guerri C; Miñarro J Neurotoxicol Teratol; 2009; 31(1):49-59. PubMed ID: 18718862 [TBL] [Abstract][Full Text] [Related]
54. Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits. Parrott AC; Lees A; Garnham NJ; Jones M; Wesnes K J Psychopharmacol; 1998; 12(1):79-83. PubMed ID: 9584971 [TBL] [Abstract][Full Text] [Related]
55. Caffeine induces a profound and persistent tachycardia in response to MDMA ("Ecstasy") administration. McNamara R; Maginn M; Harkin A Eur J Pharmacol; 2007 Jan; 555(2-3):194-8. PubMed ID: 17126829 [TBL] [Abstract][Full Text] [Related]
56. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love"). McNamara R; Kerans A; O'Neill B; Harkin A Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283 [TBL] [Abstract][Full Text] [Related]
57. N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy'). Baumann MH; Clark RD; Budzynski AG; Partilla JS; Blough BE; Rothman RB Neuropsychopharmacology; 2005 Mar; 30(3):550-60. PubMed ID: 15496938 [TBL] [Abstract][Full Text] [Related]
58. MDMA ('Ecstasy'), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors. Ramos L; Hicks C; Caminer A; Couto K; Narlawar R; Kassiou M; McGregor IS Pharmacol Biochem Behav; 2016; 150-151():115-123. PubMed ID: 27725273 [TBL] [Abstract][Full Text] [Related]
59. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 4 h apart Human pharmacology of MDMA after repeated doses taken 4 h apart. Farré M; Tomillero A; Pérez-Mañá C; Yubero S; Papaseit E; Roset PN; Pujadas M; Torrens M; Camí J; de la Torre R Eur Neuropsychopharmacol; 2015 Oct; 25(10):1637-49. PubMed ID: 26073279 [TBL] [Abstract][Full Text] [Related]
60. MDMA and performance under a progressive-ratio schedule of water delivery. Laraway S; Snycerski S; Poling A Exp Clin Psychopharmacol; 2003 Nov; 11(4):309-16. PubMed ID: 14599265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]